EL-22

N/A

Report date: 2026/03/17 20:00:15

Base Information

Drug NameEL-22
Drug Alias NameEL-22
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMOA Life Plus Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPMGC Holdings IncMOA Life Plus Co Ltd
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A